hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma.
Perera S, Jang GH, Wang Y, Kelly D, Allen M, Zhang A, Denroche RE, Dodd A, Ramotar S, Hutchinson S, Tehfe M, Ramjeesingh R, Biagi J, Lam B, Wilson J, Fischer SE, Zogopoulos G, Notta F, Gallinger S, Grant RC, Knox JJ, O'Kane GM.
Perera S, et al.
Clin Cancer Res. 2022 Dec 1;28(23):5115-5120. doi: 10.1158/1078-0432.CCR-22-2576.
Clin Cancer Res. 2022.
PMID: 36222851